Cocultures of human colorectal tumor spheroids with immune cells reveal the therapeutic potential of MICA/B and NKG2A targeting for cancer treatment

Abstract Background Immunotherapies still fail to benefit colorectal cancer (CRC) patients. Relevant functional assays aimed at studying these failures and the efficacy of cancer immunotherapy in human are scarce. 3D tumor cultures, called tumor organoids or spheroids, represent interesting models t...

詳細記述

書誌詳細
出版年:Journal for ImmunoTherapy of Cancer
主要な著者: Tristan Courau, Julie Bonnereau, Justine Chicoteau, Hugo Bottois, Romain Remark, Laura Assante Miranda, Antoine Toubert, Mathieu Blery, Thomas Aparicio, Matthieu Allez, Lionel Le Bourhis
フォーマット: 論文
言語:英語
出版事項: BMJ Publishing Group 2019-03-01
主題:
オンライン・アクセス:http://link.springer.com/article/10.1186/s40425-019-0553-9
_version_ 1857035872604520448
author Tristan Courau
Julie Bonnereau
Justine Chicoteau
Hugo Bottois
Romain Remark
Laura Assante Miranda
Antoine Toubert
Mathieu Blery
Thomas Aparicio
Matthieu Allez
Lionel Le Bourhis
author_facet Tristan Courau
Julie Bonnereau
Justine Chicoteau
Hugo Bottois
Romain Remark
Laura Assante Miranda
Antoine Toubert
Mathieu Blery
Thomas Aparicio
Matthieu Allez
Lionel Le Bourhis
author_sort Tristan Courau
collection DOAJ
container_title Journal for ImmunoTherapy of Cancer
description Abstract Background Immunotherapies still fail to benefit colorectal cancer (CRC) patients. Relevant functional assays aimed at studying these failures and the efficacy of cancer immunotherapy in human are scarce. 3D tumor cultures, called tumor organoids or spheroids, represent interesting models to study cancer treatments and could help to challenge these issues. Methods We analyzed heterotypic cocultures of human colon tumor-derived spheroids with immune cells to assess the infiltration, activation and function of T and NK cells toward human colorectal tumors in vitro. Results We showed that allogeneic T and NK cells rapidly infiltrated cell line-derived spheroids, inducing immune-mediated tumor cell apoptosis and spheroid destruction. NKG2D, a key activator of cytotoxic responses, was engaged on infiltrating cells. We thus assessed the therapeutic potential of an antibody targeting the specific ligands of NKG2D, MICA and MICB, in this system. Anti-MICA/B enhanced immune-dependent destruction of tumor spheroid by driving an increased NK cells infiltration and activation. Interestingly, tumor cells reacted to immune infiltration by upregulating HLA-E, ligand of the inhibitory receptor NKG2A expressed by CD8 and NK cells. NKG2A was increased after anti-MICA/B treatment and, accordingly, combination of anti-MICA/B and anti-NKG2A was synergistic. These observations were ultimately confirmed in a clinical relevant model of coculture between CRC patients-derived spheroids and autologous tumor-infiltrating lymphocytes. Conclusions Altogether, we show that tumor spheroids represent a relevant tool to study tumor-lymphocyte interactions on human tissues and revealed the antitumor potential of immunomodulatory antibodies targeting MICA/B and NKG2A.
format Article
id doaj-art-e00a7e04f8354b2fb9578b158b9a2194
institution Directory of Open Access Journals
issn 2051-1426
language English
publishDate 2019-03-01
publisher BMJ Publishing Group
record_format Article
spelling doaj-art-e00a7e04f8354b2fb9578b158b9a21942025-08-19T19:38:25ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262019-03-017111410.1186/s40425-019-0553-9Cocultures of human colorectal tumor spheroids with immune cells reveal the therapeutic potential of MICA/B and NKG2A targeting for cancer treatmentTristan Courau0Julie Bonnereau1Justine Chicoteau2Hugo Bottois3Romain Remark4Laura Assante Miranda5Antoine Toubert6Mathieu Blery7Thomas Aparicio8Matthieu Allez9Lionel Le Bourhis10INSERM U1160, Institut de Recherche Saint-Louis, Saint Louis HospitalINSERM U1160, Institut de Recherche Saint-Louis, Saint Louis HospitalINSERM U1160, Institut de Recherche Saint-Louis, Saint Louis HospitalINSERM U1160, Institut de Recherche Saint-Louis, Saint Louis HospitalInnate PharmaInnate PharmaINSERM U1160, Institut de Recherche Saint-Louis, Saint Louis HospitalInnate PharmaINSERM U1160, Institut de Recherche Saint-Louis, Saint Louis HospitalINSERM U1160, Institut de Recherche Saint-Louis, Saint Louis HospitalINSERM U1160, Institut de Recherche Saint-Louis, Saint Louis HospitalAbstract Background Immunotherapies still fail to benefit colorectal cancer (CRC) patients. Relevant functional assays aimed at studying these failures and the efficacy of cancer immunotherapy in human are scarce. 3D tumor cultures, called tumor organoids or spheroids, represent interesting models to study cancer treatments and could help to challenge these issues. Methods We analyzed heterotypic cocultures of human colon tumor-derived spheroids with immune cells to assess the infiltration, activation and function of T and NK cells toward human colorectal tumors in vitro. Results We showed that allogeneic T and NK cells rapidly infiltrated cell line-derived spheroids, inducing immune-mediated tumor cell apoptosis and spheroid destruction. NKG2D, a key activator of cytotoxic responses, was engaged on infiltrating cells. We thus assessed the therapeutic potential of an antibody targeting the specific ligands of NKG2D, MICA and MICB, in this system. Anti-MICA/B enhanced immune-dependent destruction of tumor spheroid by driving an increased NK cells infiltration and activation. Interestingly, tumor cells reacted to immune infiltration by upregulating HLA-E, ligand of the inhibitory receptor NKG2A expressed by CD8 and NK cells. NKG2A was increased after anti-MICA/B treatment and, accordingly, combination of anti-MICA/B and anti-NKG2A was synergistic. These observations were ultimately confirmed in a clinical relevant model of coculture between CRC patients-derived spheroids and autologous tumor-infiltrating lymphocytes. Conclusions Altogether, we show that tumor spheroids represent a relevant tool to study tumor-lymphocyte interactions on human tissues and revealed the antitumor potential of immunomodulatory antibodies targeting MICA/B and NKG2A.http://link.springer.com/article/10.1186/s40425-019-0553-9ImmunotherapyColorectal cancerSpheroidsNKG2AMICA/B
spellingShingle Tristan Courau
Julie Bonnereau
Justine Chicoteau
Hugo Bottois
Romain Remark
Laura Assante Miranda
Antoine Toubert
Mathieu Blery
Thomas Aparicio
Matthieu Allez
Lionel Le Bourhis
Cocultures of human colorectal tumor spheroids with immune cells reveal the therapeutic potential of MICA/B and NKG2A targeting for cancer treatment
Immunotherapy
Colorectal cancer
Spheroids
NKG2A
MICA/B
title Cocultures of human colorectal tumor spheroids with immune cells reveal the therapeutic potential of MICA/B and NKG2A targeting for cancer treatment
title_full Cocultures of human colorectal tumor spheroids with immune cells reveal the therapeutic potential of MICA/B and NKG2A targeting for cancer treatment
title_fullStr Cocultures of human colorectal tumor spheroids with immune cells reveal the therapeutic potential of MICA/B and NKG2A targeting for cancer treatment
title_full_unstemmed Cocultures of human colorectal tumor spheroids with immune cells reveal the therapeutic potential of MICA/B and NKG2A targeting for cancer treatment
title_short Cocultures of human colorectal tumor spheroids with immune cells reveal the therapeutic potential of MICA/B and NKG2A targeting for cancer treatment
title_sort cocultures of human colorectal tumor spheroids with immune cells reveal the therapeutic potential of mica b and nkg2a targeting for cancer treatment
topic Immunotherapy
Colorectal cancer
Spheroids
NKG2A
MICA/B
url http://link.springer.com/article/10.1186/s40425-019-0553-9
work_keys_str_mv AT tristancourau coculturesofhumancolorectaltumorspheroidswithimmunecellsrevealthetherapeuticpotentialofmicabandnkg2atargetingforcancertreatment
AT juliebonnereau coculturesofhumancolorectaltumorspheroidswithimmunecellsrevealthetherapeuticpotentialofmicabandnkg2atargetingforcancertreatment
AT justinechicoteau coculturesofhumancolorectaltumorspheroidswithimmunecellsrevealthetherapeuticpotentialofmicabandnkg2atargetingforcancertreatment
AT hugobottois coculturesofhumancolorectaltumorspheroidswithimmunecellsrevealthetherapeuticpotentialofmicabandnkg2atargetingforcancertreatment
AT romainremark coculturesofhumancolorectaltumorspheroidswithimmunecellsrevealthetherapeuticpotentialofmicabandnkg2atargetingforcancertreatment
AT lauraassantemiranda coculturesofhumancolorectaltumorspheroidswithimmunecellsrevealthetherapeuticpotentialofmicabandnkg2atargetingforcancertreatment
AT antoinetoubert coculturesofhumancolorectaltumorspheroidswithimmunecellsrevealthetherapeuticpotentialofmicabandnkg2atargetingforcancertreatment
AT mathieublery coculturesofhumancolorectaltumorspheroidswithimmunecellsrevealthetherapeuticpotentialofmicabandnkg2atargetingforcancertreatment
AT thomasaparicio coculturesofhumancolorectaltumorspheroidswithimmunecellsrevealthetherapeuticpotentialofmicabandnkg2atargetingforcancertreatment
AT matthieuallez coculturesofhumancolorectaltumorspheroidswithimmunecellsrevealthetherapeuticpotentialofmicabandnkg2atargetingforcancertreatment
AT lionellebourhis coculturesofhumancolorectaltumorspheroidswithimmunecellsrevealthetherapeuticpotentialofmicabandnkg2atargetingforcancertreatment